Drug Clinical Trial Research Department

The Department of Drug Clinical Trial Research is the Office of the National Drug Clinical Trial Institution of Qingdao Municipal Hospital. In 2020, in accordance with the requirements of the NMPA, it completed the registration of the clinical trial institution, with 17 registered drug clinical trial specialties, namely Gastroenterology, Cardiology, Ophthalmology, Otolaryngology, Anesthesiology, Infectious Diseases (Hepatitis), Nephrology, Dermatology, Respiratory Medicine, Neurology, Endocrinology, Urology, Oncology, Rheumatology and Immunology, Traditional Chinese Medicine Internal Medicine, Hematology, and Phase I Clinical Trials. There are 13 registered medical device clinical trial specialties, namely Respiratory Medicine, Cardiology, Urology, Burn Surgery, Gynecology, Ophthalmology, Dermatology, Otolaryngology, Infectious Diseases (Hepatitis), Pain Medicine, Ultrasonic Diagnosis, Medical Laboratory Medicine, and Interventional Radiology.

There are currently 3 doctors with doctoral degrees and 4 with master’s degrees, including 2 with senior professional titles, 1 deputy chief pharmacist, and 4 in-charge pharmacists. It has undertaken and successfully completed more than 500 new drug clinical research projects, including nearly 20 projects as the leading institution, and has undertaken more than 40 international multicenter projects. In 2013, it undertook the national “12th Five-Year Plan” Major New Drug Development Science and Technology Major Project, “Establishment of an Internationally Standardized Clinical Trial Technology Platform for Drugs for Autoimmune Diseases and Neurodegenerative Diseases.” In 2021, together with the Qingdao Institute for Food and Drug Control, it jointly applied for the APEC International Clinical Multicenter Joint Laboratory with the National Medical Products Administration’s “Key Laboratory for Quality Research and Evaluation of Marine Traditional Chinese Medicines,” which was approved. The National Drug Clinical Trial Institution of our hospital continuously improves its quality assurance system and quality control system and continuously enhances the quality of clinical trials. In accordance with the requirements of GCP and relevant laws and regulations, the institution’s various specialty departments organize and implement clinical trials of new drugs in all phases. It has undergone inspections by national- and provincial-level drug regulatory authorities many times and has consistently received unanimous praise from inspection expert groups and health administrative authorities at all levels. It effectively ensures that clinical trial designs are scientific, processes are standardized, and results are authentic and reliable.

Editing time: 2026/5/20 15:43:59